Department of Medical Sciences, School of Medicine, Iran University of Medical Sciences, 14496 14535 Tehran, Iran.
Department of Neuroscience and Addiction Studies, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, 14177 55469 Tehran, Iran.
J Integr Neurosci. 2024 Apr 10;23(4):77. doi: 10.31083/j.jin2304077.
Motor neuron diseases (MNDs) are progressive neurodegenerative disorders characterized by motor impairment and non-motor symptoms. The involvement of the thalamus in MNDs, especially in conditions such as amyotrophic lateral sclerosis (ALS), and its interaction with frontotemporal dementia (FTD), has garnered increasing research interest. This systematic review analyzed magnetic resonance imaging (MRI) studies that focused on thalamic alterations in MNDs to understand the significance of these changes and their correlation with clinical outcomes.
Following PRISMA 2020 guidelines, the PubMed and Scopus databases were searched from inception to June 2023 for studies related to MRI findings in the thalamus of patients with MNDs. Eligible studies included adult patients diagnosed with ALS or other forms of MND who underwent brain MRI, with outcomes related to thalamic alterations. Studies were evaluated for risk of bias using the Newcastle-Ottawa scale.
A total of 52 studies (including 3009 MND patients and 2181 healthy controls) used various MRI techniques, including volumetric analysis, diffusion tensor imaging, and functional MRI, to measure thalamic volume, connectivity, and other alterations. This review confirmed significant thalamic changes in MNDs, such as atrophy and microstructural degradation, which are associated with disease severity, progression, and functional disability. Thalamic involvement varies across different MND subtypes and is influenced by the presence of cognitive impairment and mutations in genes including chromosome 9 open reading frame 72 (). The synthesis of findings across studies indicates that thalamic pathology is a prevalent early biomarker of MNDs that contributes to motor and cognitive deficits. The thalamus is a promising target for monitoring as its dysfunction underpins a variety of clinical symptoms in MNDs.
Thalamic alterations provide valuable insights into the pathophysiology and progression of MNDs. Multimodal MRI techniques are potent tools for detecting dynamic thalamic changes, indicating structural integrity, connectivity disruption, and metabolic activity.
运动神经元病(MNDs)是一种进行性神经退行性疾病,其特征是运动功能障碍和非运动症状。丘脑在 MNDs 中的作用,特别是在肌萎缩侧索硬化症(ALS)等疾病中,以及它与额颞叶痴呆(FTD)的相互作用,引起了越来越多的研究兴趣。本系统综述分析了专注于 MNDs 中丘脑改变的磁共振成像(MRI)研究,以了解这些变化的意义及其与临床结果的相关性。
根据 PRISMA 2020 指南,从成立到 2023 年 6 月,在 PubMed 和 Scopus 数据库中搜索了与 MND 患者丘脑 MRI 结果相关的研究。纳入的研究包括成年患者诊断为 ALS 或其他形式的 MND,接受了脑部 MRI 检查,并与丘脑改变的结果相关。使用纽卡斯尔-渥太华量表评估研究的偏倚风险。
共有 52 项研究(包括 3009 名 MND 患者和 2181 名健康对照者)使用了各种 MRI 技术,包括容积分析、弥散张量成像和功能 MRI,以测量丘脑体积、连接和其他改变。本综述证实了 MND 中存在明显的丘脑改变,如萎缩和微观结构退化,这些改变与疾病严重程度、进展和功能障碍相关。不同的 MND 亚型中丘脑的受累情况不同,并且受到认知障碍和包括 9 号染色体开放阅读框 72()在内的基因突变的影响。对研究结果的综合分析表明,丘脑病理学是 MNDs 的一种普遍的早期生物标志物,导致运动和认知缺陷。丘脑是一个有前途的监测靶点,因为其功能障碍是 MNDs 中多种临床症状的基础。
丘脑改变为 MNDs 的病理生理学和进展提供了有价值的见解。多模态 MRI 技术是检测动态丘脑变化的有力工具,可指示结构完整性、连接中断和代谢活性。